Search

Your search keyword '"Bartolotta, R"' showing total 22 results
Start Over Author "Bartolotta, R"
22 results on '"Bartolotta, R"'

3. Comorbidities, cardiovascular therapies, and COVID-19 mortality: A nationwide, italian observational study (ItaliCO)

Author

Polverino, F, Stern, D, Ruocco, G, Balestro, E, Bassetti, M, Candelli, M, Cirillo, B, Contoli, M, Corsico, A, D'Amico, F, D'Elia, E, Falco, G, Gasparini, S, Guerra, S, Harari, S, Kraft, M, Mennella, L, Papi, A, Parrella, R, Pelosi, P, Poletti, V, Polverino, M, Tana, C, Terribile, R, Woods, J, Di Marco, F, Martinez, F, Zhang, S, Geelhoed, B, Sinning, C, Agarossi, A, Agati, S, Agosteo, E, Ando', F, Andreoni, M, Angelillo, I, Arcoleo, G, Arena, C, Baiamonte, P, Ball, L, Banfi, P, Bartoletti, G, Bartolotta, R, Battaglini, D, Bellan, M, Benzoni, I, Bertolini, R, Bevilacqua, M, Bezzi, M, Bianco, A, Bisbano, A, Bobbio, F, Bocchialini, G, Bonetti, F, Boni, F, Bonifazi, M, Borgonovo, G, Borre', S, Bosio, M, Brachini, G, Brunetti, I, Calagna, L, Calo, F, Capuozzo, A, Carr, T, Castellani, A, Catalano, F, Catania, G, Catena, E, Cattaneo, M, Cattelan, A, Ceruti, V, Chiumiento, F, Cicchitto, G, Confalonieri, M, Confalonieri, P, Coppola, N, Cosentina, R, Costantino, R, Crimi, C, Curra, A, D'Abbraccio, M, Dalbeni, A, Daleffe, F, Davide, R, Del Donno, M, Di Pastena, F, Di Perna, F, Di Rosa, Z, Di Sabatino, A, Elesbani, O, Elia, D, Esposito, V, Fabiani, L, Falo, G, Fanelli, C, Fantin, A, Ferrigno, F, Fiorentino, G, Franceschi, F, Fronza, M, Gardenghi, G, Giacobbe, D, Giannotti, C, Giannotti, G, Gidari, A, Giovanardi, F, Gnerre, P, Gonnelli, F, Graziano, M, Greco, S, Grosso, A, Guarino, S, Iannarelli, A, Imitazione, P, Inglese, F, Iodice, V, Izzo, A, La Greca, C, Lax, A, Legittimo, F, Leo, A, Leone, S, Lepidini, V, Leto, M, Licata, F, Locati, F, Lorini, L, Lucchetti, B, Maida, I, Macera, M, Manzillo, E, March, A, Mascheroni, D, Mastroianni, A, Mauro, I, Mazzitelli, M, Mazzuca, E, Micheletto, C, Mingoli, A, Minuz, P, Moioli, M, Monti, L, Morgagni, R, Mucci, L, Muselli, M, Negri, S, Nobile, C, Oldani, S, Olivieri, C, Parati, G, Parodi, L, Pastorelli, E, Patruno, V, Pellegrino, F, Pengo, M, Pepe, D, Perotti, A, Petrino, R, Petrucci, M, Piane, R, Pignataro, G, Pino, M, Pirisi, M, Porru, F, Pugliese, F, Punzi, R, Ramaroli, D, Robba, C, Rostagno, R, Sabatini, U, Sainaghi, P, Salton, F, Salzano, C, Sanduzzi, A, Zamparelli, S, Sangiovanni, V, Santopuoli, D, Sapienza, P, Sarmati, L, Schiaroli, E, Scienza, F, Senni, M, Serchisu, L, Sgherzi, S, Soddu, D, Soranna, D, Sorino, C, Spadaro, S, Stirpe, E, Tardivo, S, Tartaglia, S, Teopompi, E, Tomchaney, M, Torelli, E, Torlasco, C, Torti, C, Tupputi, E, Ugolinelli, C, Vatrella, A, Versace, A, Villani, M, Vincenzo, L, Volta, C, Voraphani, N, Zekaj, E, Zoppellari, R, Polverino F., Stern D. A., Ruocco G., Balestro E., Bassetti M., Candelli M., Cirillo B., Contoli M., Corsico A., D'Amico F., D'Elia E., Falco G., Gasparini S., Guerra S., Harari S., Kraft M., Mennella L., Papi A., Parrella R., Pelosi P., Poletti V., Polverino M., Tana C., Terribile R., Woods J. C., Di Marco F., Martinez F. D., Zhang S., Geelhoed B., Sinning C., Agarossi A., Agati S., Agosteo E., Ando' F., Andreoni M., Angelillo I. F., Arcoleo G., Arena C., Baiamonte P., Ball L., Banfi P., Bartoletti G., Bartolotta R., Battaglini D., Bellan M., Benzoni I., Bertolini R., Bevilacqua M., Bezzi M., Bianco A., Bisbano A., Bobbio F., Bocchialini G., Bonetti F., Boni F., Bonifazi M., Borgonovo G., Borre' S., Bosio M., Brachini G., Brunetti I., Calagna L., Calo F., Capuozzo A., Carr T., Castellani A., Catalano F., Catania G., Catena E., Cattaneo M., Cattelan A., Ceruti V., Chiumiento F., Cicchitto G., Confalonieri M., Confalonieri P., Coppola N., Cosentina R., Costantino R., Crimi C., Curra A., D'Abbraccio M., Dalbeni A., Daleffe F., Davide R., Del Donno M., Di Pastena F., Di Perna F., Di Rosa Z., Di Sabatino A., Elesbani O., Elia D., Esposito V., Fabiani L., Falo G., Fanelli C., Fantin A., Ferrigno F., Fiorentino G., Franceschi F., Fronza M., Gardenghi G. G., Giacobbe D. R., Giannotti C., Giannotti G., Gidari A., Giovanardi F., Gnerre P., Gonnelli F., Graziano M., Greco S., Grosso A., Guarino S., Iannarelli A., Imitazione P., Inglese F., Iodice V., Izzo A., La Greca C., Lax A., Legittimo F., Leo A., Leone S., Lepidini V., Leto M., Licata F., Locati F., Lorini L., Lucchetti B., Maida I., Macera M., Manzillo E., March A., Mascheroni D., Mastroianni A., Mauro I., Mazzitelli M., Mazzuca E., Micheletto C., Mingoli A., Minuz P., Moioli M., Monti L., Morgagni R., Mucci L., Muselli M., Negri S., Nobile C. G. A., Oldani S., Olivieri C., Parati G., Parodi L., Pastorelli E., Patruno V., Pellegrino F., Pengo M. F., Pepe D., Perotti A., Petrino R., Petrucci M., Piane R. M., Pignataro G., Pino M., Pirisi M., Porru F., Pugliese F., Punzi R., Ramaroli D. A., Robba C., Rostagno R., Sabatini U., Sainaghi P. P., Salton F., Salzano C., Sanduzzi A., Zamparelli S. S., Sangiovanni V., Santopuoli D., Sapienza P., Sarmati L., Schiaroli E., Scienza F., Senni M., Serchisu L., Sgherzi S., Soddu D., Soranna D., Sorino C., Spadaro S., Stirpe E., Tardivo S., Tartaglia S., Teopompi E., Tomchaney M., Torelli E., Torlasco C., Torti C., Tupputi E., Ugolinelli C., Vatrella A., Versace A. G., Villani M., Vincenzo L., Volta C. A., Voraphani N., Zekaj E., Zoppellari R., Polverino, F, Stern, D, Ruocco, G, Balestro, E, Bassetti, M, Candelli, M, Cirillo, B, Contoli, M, Corsico, A, D'Amico, F, D'Elia, E, Falco, G, Gasparini, S, Guerra, S, Harari, S, Kraft, M, Mennella, L, Papi, A, Parrella, R, Pelosi, P, Poletti, V, Polverino, M, Tana, C, Terribile, R, Woods, J, Di Marco, F, Martinez, F, Zhang, S, Geelhoed, B, Sinning, C, Agarossi, A, Agati, S, Agosteo, E, Ando', F, Andreoni, M, Angelillo, I, Arcoleo, G, Arena, C, Baiamonte, P, Ball, L, Banfi, P, Bartoletti, G, Bartolotta, R, Battaglini, D, Bellan, M, Benzoni, I, Bertolini, R, Bevilacqua, M, Bezzi, M, Bianco, A, Bisbano, A, Bobbio, F, Bocchialini, G, Bonetti, F, Boni, F, Bonifazi, M, Borgonovo, G, Borre', S, Bosio, M, Brachini, G, Brunetti, I, Calagna, L, Calo, F, Capuozzo, A, Carr, T, Castellani, A, Catalano, F, Catania, G, Catena, E, Cattaneo, M, Cattelan, A, Ceruti, V, Chiumiento, F, Cicchitto, G, Confalonieri, M, Confalonieri, P, Coppola, N, Cosentina, R, Costantino, R, Crimi, C, Curra, A, D'Abbraccio, M, Dalbeni, A, Daleffe, F, Davide, R, Del Donno, M, Di Pastena, F, Di Perna, F, Di Rosa, Z, Di Sabatino, A, Elesbani, O, Elia, D, Esposito, V, Fabiani, L, Falo, G, Fanelli, C, Fantin, A, Ferrigno, F, Fiorentino, G, Franceschi, F, Fronza, M, Gardenghi, G, Giacobbe, D, Giannotti, C, Giannotti, G, Gidari, A, Giovanardi, F, Gnerre, P, Gonnelli, F, Graziano, M, Greco, S, Grosso, A, Guarino, S, Iannarelli, A, Imitazione, P, Inglese, F, Iodice, V, Izzo, A, La Greca, C, Lax, A, Legittimo, F, Leo, A, Leone, S, Lepidini, V, Leto, M, Licata, F, Locati, F, Lorini, L, Lucchetti, B, Maida, I, Macera, M, Manzillo, E, March, A, Mascheroni, D, Mastroianni, A, Mauro, I, Mazzitelli, M, Mazzuca, E, Micheletto, C, Mingoli, A, Minuz, P, Moioli, M, Monti, L, Morgagni, R, Mucci, L, Muselli, M, Negri, S, Nobile, C, Oldani, S, Olivieri, C, Parati, G, Parodi, L, Pastorelli, E, Patruno, V, Pellegrino, F, Pengo, M, Pepe, D, Perotti, A, Petrino, R, Petrucci, M, Piane, R, Pignataro, G, Pino, M, Pirisi, M, Porru, F, Pugliese, F, Punzi, R, Ramaroli, D, Robba, C, Rostagno, R, Sabatini, U, Sainaghi, P, Salton, F, Salzano, C, Sanduzzi, A, Zamparelli, S, Sangiovanni, V, Santopuoli, D, Sapienza, P, Sarmati, L, Schiaroli, E, Scienza, F, Senni, M, Serchisu, L, Sgherzi, S, Soddu, D, Soranna, D, Sorino, C, Spadaro, S, Stirpe, E, Tardivo, S, Tartaglia, S, Teopompi, E, Tomchaney, M, Torelli, E, Torlasco, C, Torti, C, Tupputi, E, Ugolinelli, C, Vatrella, A, Versace, A, Villani, M, Vincenzo, L, Volta, C, Voraphani, N, Zekaj, E, Zoppellari, R, Polverino F., Stern D. A., Ruocco G., Balestro E., Bassetti M., Candelli M., Cirillo B., Contoli M., Corsico A., D'Amico F., D'Elia E., Falco G., Gasparini S., Guerra S., Harari S., Kraft M., Mennella L., Papi A., Parrella R., Pelosi P., Poletti V., Polverino M., Tana C., Terribile R., Woods J. C., Di Marco F., Martinez F. D., Zhang S., Geelhoed B., Sinning C., Agarossi A., Agati S., Agosteo E., Ando' F., Andreoni M., Angelillo I. F., Arcoleo G., Arena C., Baiamonte P., Ball L., Banfi P., Bartoletti G., Bartolotta R., Battaglini D., Bellan M., Benzoni I., Bertolini R., Bevilacqua M., Bezzi M., Bianco A., Bisbano A., Bobbio F., Bocchialini G., Bonetti F., Boni F., Bonifazi M., Borgonovo G., Borre' S., Bosio M., Brachini G., Brunetti I., Calagna L., Calo F., Capuozzo A., Carr T., Castellani A., Catalano F., Catania G., Catena E., Cattaneo M., Cattelan A., Ceruti V., Chiumiento F., Cicchitto G., Confalonieri M., Confalonieri P., Coppola N., Cosentina R., Costantino R., Crimi C., Curra A., D'Abbraccio M., Dalbeni A., Daleffe F., Davide R., Del Donno M., Di Pastena F., Di Perna F., Di Rosa Z., Di Sabatino A., Elesbani O., Elia D., Esposito V., Fabiani L., Falo G., Fanelli C., Fantin A., Ferrigno F., Fiorentino G., Franceschi F., Fronza M., Gardenghi G. G., Giacobbe D. R., Giannotti C., Giannotti G., Gidari A., Giovanardi F., Gnerre P., Gonnelli F., Graziano M., Greco S., Grosso A., Guarino S., Iannarelli A., Imitazione P., Inglese F., Iodice V., Izzo A., La Greca C., Lax A., Legittimo F., Leo A., Leone S., Lepidini V., Leto M., Licata F., Locati F., Lorini L., Lucchetti B., Maida I., Macera M., Manzillo E., March A., Mascheroni D., Mastroianni A., Mauro I., Mazzitelli M., Mazzuca E., Micheletto C., Mingoli A., Minuz P., Moioli M., Monti L., Morgagni R., Mucci L., Muselli M., Negri S., Nobile C. G. A., Oldani S., Olivieri C., Parati G., Parodi L., Pastorelli E., Patruno V., Pellegrino F., Pengo M. F., Pepe D., Perotti A., Petrino R., Petrucci M., Piane R. M., Pignataro G., Pino M., Pirisi M., Porru F., Pugliese F., Punzi R., Ramaroli D. A., Robba C., Rostagno R., Sabatini U., Sainaghi P. P., Salton F., Salzano C., Sanduzzi A., Zamparelli S. S., Sangiovanni V., Santopuoli D., Sapienza P., Sarmati L., Schiaroli E., Scienza F., Senni M., Serchisu L., Sgherzi S., Soddu D., Soranna D., Sorino C., Spadaro S., Stirpe E., Tardivo S., Tartaglia S., Teopompi E., Tomchaney M., Torelli E., Torlasco C., Torti C., Tupputi E., Ugolinelli C., Vatrella A., Versace A. G., Villani M., Vincenzo L., Volta C. A., Voraphani N., Zekaj E., and Zoppellari R.

Abstract

Background: Italy has one of the world’s oldest populations, and suffered one the highest death tolls from Coronavirus disease 2019 (COVID-19) worldwide. Older people with cardiovascular diseases (CVDs), and in particular hypertension, are at higher risk of hospitalization and death for COVID-19. Whether hypertensionmedicationsmay increase the risk for death in older COVID 19 inpatients at the highest risk for the disease is currently unknown. Methods: Data from 5,625 COVID-19 inpatients were manually extracted from medical charts from 61 hospitals across Italy. From the initial 5,625 patients, 3,179 were included in the study as they were either discharged or deceased at the time of the data analysis. Primary outcome was inpatient death or recovery. Mixed effects logistic regression models were adjusted for sex, age, and number of comorbidities, with a random effect for site. Results: A large proportion of participating inpatients were ≥65 years old (58%), male (68%), non-smokers (93%) with comorbidities (66%). Each additional comorbidity increased the risk of death by 35% [adjOR = 1.35 (1.2, 1.5) p < 0.001]. Use of ACE inhibitors, ARBs, beta-blockers or Ca-antagonists was not associated with significantly increased risk of death. There was a marginal negative association between ARB use and death, and a marginal positive association between diuretic use and death. Conclusions: This Italian nationwide observational study of COVID-19 inpatients, the majority of which ≥65 years old, indicates that there is a linear direct relationship between the number of comorbidities and the risk of death. Among CVDs, hypertension and pre-existing cardiomyopathy were significantly associated with risk of death. The use of hypertension medications reported to be safe in younger cohorts, do not contribute significantly to increased COVID-19 related deaths in an older population that suffered one of the highest death tolls worldwide.

Published
2020

4. Comorbidities, cardiovascular therapies, and COVID-19 mortality: A nationwide, italian observational study (ItaliCO)

Author

Polverino, F., Phd, Md, Stern, D., Polverino, M., D'Amico, F., D'Elia, E., Agarossi, A., Agati, S., Agosteo, E., Ando', F., Andreoni, M., Angelillo, If., Dds, Mph, Arcoleo, G., Arena, C., Baiamonte, P., Balestro, E., Ball, L., Banfi, P., Bartoletti, G., Bartolotta, R., Bassetti, M., Battaglini, D., Bellan, M., Benzoni, I., Bertolini, R., Bevilacqua, M., Bezzi, M., Bianco, A., Bisbano, A., Bobbio, F., Bocchialini, G., Bonetti, F., Boni, F., Bonifazi, M., Borgonovo, G., Borre', S., Bosio, M., Brachini, G., Brunetti, I., Calagna, L., Calò, F., Candelli, M., Capuozzo, A., Carr, T., Castellani, A., Catalano, F., Catania, G., Catena, E., Cattaneo, M., Cattelan, A., Ceruti, V., Chiumiento, F., Cicchitto, G., Cirillo, B., Confalonieri, M., Confalonieri, P., Contoli, M., Coppola, N., Corsico, A., Cosentina, R., Costantino, R., Crimi, C., Currà, A., D'Abbraccio, M., Dalbeni, A., Daleffe, F., Davide, R., Del Donno, M., Di Marco, F., Di Pastena, F., Di Perna, F., Di Rosa, Z., Di Sabatino, A., Elesbani, O., Elia, D., Esposito, V., Fabiani, L., Falco, G., Falo, G., Fanelli, C., Fantin, A., Ferrigno, F., Fiorentino, G., Franceschi, F., Fronza, M., Gardini Gardenghi, G., Gasparini, S., Giacobbe, D. R., Giannotti, C., Giannotti, G., Gidari, A., Giovanardi, F., Gnerre, P., Gonnelli, F., Graziano, M., Greco, S., Grosso, A., Phd, Guarino, S., Guerra, S., Harari, S., Iannarelli, A., Imitazione, P., Inglese, F., Iodice, V., Izzo, A., La Greca, C., Kraft, M., Lax, A., Legittimo, F., Leo, A., Leone, S., Lepidini, V., Leto, M., Licata, F., Locati, F., Lorini, L., Lucchetti, B., Maida, I., Macera, M., Manzillo, E., March, A., Mascheroni, D., Mastroianni, A., Mauro, I., Mazzitelli, M., Mazzuca, E., Mennella, L., Micheletto, C., Mingoli, A., Minuz, P., Moioli, M., Monti, L., Morgagni, R., Mucci, L., Muselli, M., Negri, S., Nobile, C. G. A., Oldani, S., Olivieri, C., Papi, A., Parati, G., Parodi, L., Parrella, R., Pastorelli, E., Patruno, V., Pellegrino, F., Pelosi, P., Fers, Md, Pengo, M. F., Pepe, D., Perotti, A., Petrino, R., Petrucci, M., Piane, R. M., Pignataro, G., Pino, M., Pirisi, M., Poletti, V., Porru, F., Pugliese, F., Punzi, R., Ramaroli, D. A., Robba, C., Rostagno, R., Ruocco, G., Sabatini, U., Sainaghi, P. P., Salton, F., Salzano, C., Sanduzzi, A., Sanduzzi Zamparelli, S., Sangiovanni, V., Santopuoli, D., Sapienza, P., Sarmati, L., Schiaroli, E., Scienza, F., Senni, M., Serchisu, L., Sgherzi, S., Soddu, D., Soranna, D., Sorino, C., Spadaro, S., Stirpe, E., Tana, C., Tardivo, S., Tartaglia, S., Teopompi, E., Terribile, R., Tomchaney, M., Torelli, E., Torlasco, C., Torti, C., Tupputi, E., Ugolinelli, C., Vatrella, A., Versace, A. G., Villani, M., Vincenzo, L., Volta, C. A., Voraphani, N., Woods, J. C., Zekaj, E., Zoppellari, R., Martinez, and F. D., Polverino, Francesca, Stern, Debra A, Ruocco, Gaetano, Balestro, Elisabetta, Bassetti, Matteo, Candelli, Marcello, Cirillo, Bruno, Contoli, Marco, Corsico, Angelo, D'Amico, Filippo, D'Elia, Emilia, Falco, Giuseppe, Gasparini, Stefano, Guerra, Stefano, Harari, Sergio, Kraft, Monica, Mennella, Luigi, Papi, Alberto, Parrella, Roberto, Pelosi, Paolo, Poletti, Venerino, Polverino, Mario, Tana, Claudio, Terribile, Roberta, Woods, Jason C, Di Marco, Fabiano, Martinez, Fernando D, Angelillo, Italo Francesco, Stern, Debra A., C Woods, Jason, Martinez, Fernando D., Polverino, F., Stern, D., Polverino, M., D'Amico, F., D'Elia, E., Agarossi, A., Agati, S., Agosteo, E., Ando', F., Andreoni, M., Angelillo, If., Arcoleo, G., Arena, C., Baiamonte, P., Balestro, E., Ball, L., Banfi, P., Bartoletti, G., Bartolotta, R., Bassetti, M., Battaglini, D., Bellan, M., Benzoni, I., Bertolini, R., Bevilacqua, M., Bezzi, M., Bianco, A., Bisbano, A., Bobbio, F., Bocchialini, G., Bonetti, F., Boni, F., Bonifazi, M., Borgonovo, G., Borre', S., Bosio, M., Brachini, G., Brunetti, I., Calagna, L., Calò, F., Candelli, M., Capuozzo, A., Carr, T., Castellani, A., Catalano, F., Catania, G., Catena, E., Cattaneo, M., Cattelan, A., Ceruti, V., Chiumiento, F., Cicchitto, G., Cirillo, B., Confalonieri, M., Confalonieri, P., Contoli, M., Coppola, N., Corsico, A., Cosentina, R., Costantino, R., Crimi, C., Currà, A., D'Abbraccio, M., Dalbeni, A., Daleffe, F., Davide, R., Del Donno, M., Di Marco, F., Di Pastena, F., Di Perna, F., Di Rosa, Z., Di Sabatino, A., Elesbani, O., Elia, D., Esposito, V., Fabiani, L., Falco, G., Falo, G., Fanelli, C., Fantin, A., Ferrigno, F., Fiorentino, G., Franceschi, F., Fronza, M., Gardini Gardenghi, G., Gasparini, S., Giacobbe, D. R., Giannotti, C., Giannotti, G., Gidari, A., Giovanardi, F., Gnerre, P., Gonnelli, F., Graziano, M., Greco, S., Grosso, A., Guarino, S., Guerra, S., Harari, S., Iannarelli, A., Imitazione, P., Inglese, F., Iodice, V., Izzo, A., La Greca, C., Kraft, M., Lax, A., Legittimo, F., Leo, A., Leone, S., Lepidini, V., Leto, M., Licata, F., Locati, F., Lorini, L., Lucchetti, B., Maida, I., Macera, M., Manzillo, E., March, A., Mascheroni, D., Mastroianni, A., Mauro, I., Mazzitelli, M., Mazzuca, E., Mennella, L., Micheletto, C., Mingoli, A., Minuz, P., Moioli, M., Monti, L., Morgagni, R., Mucci, L., Muselli, M., Negri, S., Nobile, C. G. A., Oldani, S., Olivieri, C., Papi, A., Parati, G., Parodi, L., Parrella, R., Pastorelli, E., Patruno, V., Pellegrino, F., Pelosi, P., Pengo, M. F., Pepe, D., Perotti, A., Petrino, R., Petrucci, M., Piane, R. M., Pignataro, G., Pino, M., Pirisi, M., Poletti, V., Porru, F., Pugliese, F., Punzi, R., Ramaroli, D. A., Robba, C., Rostagno, R., Ruocco, G., Sabatini, U., Sainaghi, P. P., Salton, F., Salzano, C., Sanduzzi, A., Sanduzzi Zamparelli, S., Sangiovanni, V., Santopuoli, D., Sapienza, P., Sarmati, L., Schiaroli, E., Scienza, F., Senni, M., Serchisu, L., Sgherzi, S., Soddu, D., Soranna, D., Sorino, C., Spadaro, S., Stirpe, E., Tana, C., Tardivo, S., Tartaglia, S., Teopompi, E., Terribile, R., Tomchaney, M., Torelli, E., Torlasco, C., Torti, C., Tupputi, E., Ugolinelli, C., Vatrella, A., Versace, A. G., Villani, M., Vincenzo, L., Volta, C. A., Voraphani, N., Woods, J. C., Zekaj, E., Zoppellari, R., Martinez, F. D., Public Health, Polverino, F, Stern, D, Ruocco, G, Balestro, E, Bassetti, M, Candelli, M, Cirillo, B, Contoli, M, Corsico, A, D'Amico, F, D'Elia, E, Falco, G, Gasparini, S, Guerra, S, Harari, S, Kraft, M, Mennella, L, Papi, A, Parrella, R, Pelosi, P, Poletti, V, Polverino, M, Tana, C, Terribile, R, Woods, J, Di Marco, F, Martinez, F, Zhang, S, Geelhoed, B, Sinning, C, Agarossi, A, Agati, S, Agosteo, E, Ando', F, Andreoni, M, Angelillo, I, Arcoleo, G, Arena, C, Baiamonte, P, Ball, L, Banfi, P, Bartoletti, G, Bartolotta, R, Battaglini, D, Bellan, M, Benzoni, I, Bertolini, R, Bevilacqua, M, Bezzi, M, Bianco, A, Bisbano, A, Bobbio, F, Bocchialini, G, Bonetti, F, Boni, F, Bonifazi, M, Borgonovo, G, Borre', S, Bosio, M, Brachini, G, Brunetti, I, Calagna, L, Calo, F, Capuozzo, A, Carr, T, Castellani, A, Catalano, F, Catania, G, Catena, E, Cattaneo, M, Cattelan, A, Ceruti, V, Chiumiento, F, Cicchitto, G, Confalonieri, M, Confalonieri, P, Coppola, N, Cosentina, R, Costantino, R, Crimi, C, Curra, A, D'Abbraccio, M, Dalbeni, A, Daleffe, F, Davide, R, Del Donno, M, Di Pastena, F, Di Perna, F, Di Rosa, Z, Di Sabatino, A, Elesbani, O, Elia, D, Esposito, V, Fabiani, L, Falo, G, Fanelli, C, Fantin, A, Ferrigno, F, Fiorentino, G, Franceschi, F, Fronza, M, Gardenghi, G, Giacobbe, D, Giannotti, C, Giannotti, G, Gidari, A, Giovanardi, F, Gnerre, P, Gonnelli, F, Graziano, M, Greco, S, Grosso, A, Guarino, S, Iannarelli, A, Imitazione, P, Inglese, F, Iodice, V, Izzo, A, La Greca, C, Lax, A, Legittimo, F, Leo, A, Leone, S, Lepidini, V, Leto, M, Licata, F, Locati, F, Lorini, L, Lucchetti, B, Maida, I, Macera, M, Manzillo, E, March, A, Mascheroni, D, Mastroianni, A, Mauro, I, Mazzitelli, M, Mazzuca, E, Micheletto, C, Mingoli, A, Minuz, P, Moioli, M, Monti, L, Morgagni, R, Mucci, L, Muselli, M, Negri, S, Nobile, C, Oldani, S, Olivieri, C, Parati, G, Parodi, L, Pastorelli, E, Patruno, V, Pellegrino, F, Pengo, M, Pepe, D, Perotti, A, Petrino, R, Petrucci, M, Piane, R, Pignataro, G, Pino, M, Pirisi, M, Porru, F, Pugliese, F, Punzi, R, Ramaroli, D, Robba, C, Rostagno, R, Sabatini, U, Sainaghi, P, Salton, F, Salzano, C, Sanduzzi, A, Zamparelli, S, Sangiovanni, V, Santopuoli, D, Sapienza, P, Sarmati, L, Schiaroli, E, Scienza, F, Senni, M, Serchisu, L, Sgherzi, S, Soddu, D, Soranna, D, Sorino, C, Spadaro, S, Stirpe, E, Tardivo, S, Tartaglia, S, Teopompi, E, Tomchaney, M, Torelli, E, Torlasco, C, Torti, C, Tupputi, E, Ugolinelli, C, Vatrella, A, Versace, A, Villani, M, Vincenzo, L, Volta, C, Voraphani, N, Zekaj, E, and Zoppellari, R

Subjects
0301 basic medicine, COVID-19, comorbidities, ACE inhibitors, mortality, cohort study, medicine.medical_specialty, comorbiditie, lcsh:Diseases of the circulatory (Cardiovascular) system, ACE inhibitors, Coronavirus disease 2019 (COVID-19), COVID-19, cohort study, comorbidities, mortality, Cardiomyopathy, Socio-culturale, Disease, 030204 cardiovascular system & hematology, Cardiovascular Medicine, Logistic regression, Older population, Comorbidities, 03 medical and health sciences, 0302 clinical medicine, SDG 3 - Good Health and Well-being, Internal medicine, ACE inhibitor, medicine, Mortality, Original Research, business.industry, Cohort study, medicine.disease, Comorbidity, 030104 developmental biology, lcsh:RC666-701, Observational study, Erratum, Cardiology and Cardiovascular Medicine, business
Abstract

Background: Italy has one of the world’s oldest populations, and suffered one the highest death tolls from Coronavirus disease 2019 (COVID-19) worldwide. Older people with cardiovascular diseases (CVDs), and in particular hypertension, are at higher risk of hospitalization and death for COVID-19. Whether hypertensionmedicationsmay increase the risk for death in older COVID 19 inpatients at the highest risk for the disease is currently unknown. Methods: Data from 5,625 COVID-19 inpatients were manually extracted from medical charts from 61 hospitals across Italy. From the initial 5,625 patients, 3,179 were included in the study as they were either discharged or deceased at the time of the data analysis. Primary outcome was inpatient death or recovery. Mixed effects logistic regression models were adjusted for sex, age, and number of comorbidities, with a random effect for site. Results: A large proportion of participating inpatients were ≥65 years old (58%), male (68%), non-smokers (93%) with comorbidities (66%). Each additional comorbidity increased the risk of death by 35% [adjOR = 1.35 (1.2, 1.5) p < 0.001]. Use of ACE inhibitors, ARBs, beta-blockers or Ca-antagonists was not associated with significantly increased risk of death. There was a marginal negative association between ARB use and death, and a marginal positive association between diuretic use and death. Conclusions: This Italian nationwide observational study of COVID-19 inpatients, the majority of which ≥65 years old, indicates that there is a linear direct relationship between the number of comorbidities and the risk of death. Among CVDs, hypertension and pre-existing cardiomyopathy were significantly associated with risk of death. The use of hypertension medications reported to be safe in younger cohorts, do not contribute significantly to increased COVID-19 related deaths in an older population that suffered one of the highest death tolls worldwide.

Published
2020

6. Comorbidities, cardiovascular therapies, and COVID-19 mortality:A nationwide, italian observational study (ItaliCO)

Author

Polverino, Francesca, Stern, Debra A., Ruocco, Gaetano, Balestro, Elisabetta, Bassetti, Matteo, Candelli, Marcello, Cirillo, Bruno, Contoli, Marco, Corsico, Angelo, D’Amico, Filippo, D’Elia, Emilia, Falco, Giuseppe, Gasparini, Stefano, Guerra, Stefano, Harari, Sergio, Kraft, Monica, Mennella, Luigi, Papi, Alberto, Parrella, Roberto, Pelosi, Paolo, Poletti, Venerino, Polverino, Mario, Tana, Claudio, Terribile, Roberta, Woods, Jason C., Di Marco, Fabiano, Martinez, Fernando D., Zhang, Shuyang, Geelhoed, Bastiaan, Sinning, Christoph, Agarossi, A., Agati, S., Agosteo, E., Ando’, F., Andreoni, M., Angelillo, I. F., Arcoleo, G., Arena, C., Baiamonte, P., Ball, L., Banfi, P., Bartoletti, G., Bartolotta, R., Battaglini, D., Bellan, M., Benzoni, I., Catalano, F., Grosso, A., Porru, F., Pugliese, F., Polverino, Francesca, Stern, Debra A., Ruocco, Gaetano, Balestro, Elisabetta, Bassetti, Matteo, Candelli, Marcello, Cirillo, Bruno, Contoli, Marco, Corsico, Angelo, D’Amico, Filippo, D’Elia, Emilia, Falco, Giuseppe, Gasparini, Stefano, Guerra, Stefano, Harari, Sergio, Kraft, Monica, Mennella, Luigi, Papi, Alberto, Parrella, Roberto, Pelosi, Paolo, Poletti, Venerino, Polverino, Mario, Tana, Claudio, Terribile, Roberta, Woods, Jason C., Di Marco, Fabiano, Martinez, Fernando D., Zhang, Shuyang, Geelhoed, Bastiaan, Sinning, Christoph, Agarossi, A., Agati, S., Agosteo, E., Ando’, F., Andreoni, M., Angelillo, I. F., Arcoleo, G., Arena, C., Baiamonte, P., Ball, L., Banfi, P., Bartoletti, G., Bartolotta, R., Battaglini, D., Bellan, M., Benzoni, I., Catalano, F., Grosso, A., Porru, F., and Pugliese, F.

Abstract

Background: Italy has one of the world’s oldest populations, and suffered one the highest death tolls from Coronavirus disease 2019 (COVID-19) worldwide. Older people with cardiovascular diseases (CVDs), and in particular hypertension, are at higher risk of hospitalization and death for COVID-19. Whether hypertensionmedicationsmay increase the risk for death in older COVID 19 inpatients at the highest risk for the disease is currently unknown. Methods: Data from 5,625 COVID-19 inpatients were manually extracted from medical charts from 61 hospitals across Italy. From the initial 5,625 patients, 3,179 were included in the study as they were either discharged or deceased at the time of the data analysis. Primary outcome was inpatient death or recovery. Mixed effects logistic regression models were adjusted for sex, age, and number of comorbidities, with a random effect for site. Results: A large proportion of participating inpatients were ≥65 years old (58%), male (68%), non-smokers (93%) with comorbidities (66%). Each additional comorbidity increased the risk of death by 35% [adjOR = 1.35 (1.2, 1.5) p < 0.001]. Use of ACE inhibitors, ARBs, beta-blockers or Ca-antagonists was not associated with significantly increased risk of death. There was a marginal negative association between ARB use and death, and a marginal positive association between diuretic use and death. Conclusions: This Italian nationwide observational study of COVID-19 inpatients, the majority of which ≥65 years old, indicates that there is a linear direct relationship between the number of comorbidities and the risk of death. Among CVDs, hypertension and pre-existing cardiomyopathy were significantly associated with risk of death. The use of hypertension medications reported to be safe in younger cohorts, do not contribute significantly to increased COVID-19 related deaths in an older population that suffered one of the highest death tolls worldwide.

Published
2020

8. Abstracts

Author

Frankenfeld John W., Schulz Wolfgang, McMurty George J., Petersen Gary W., May G. A., Hering F. S., Schwartz J. I., Heywood J. B., Chigier N. A., Grohse E. W., Walker J. D., Colwell R. R., Petrakis L., Pergament H. S., Thorpe R. D., Schoepf Richard W., Krzyczkowski Roman, Henneman Suzanne S., Hudson Charles L., Putnam Evelyn S., Thiesen Donna J., Parks G. A., McCarty Perry L., Leckie J. O., Schrumpf Barry J., Simonson G. H., Paine D. P., Lawrence R. D., Pyott W. T., Leh M., Elders W., Combs J., Caplen T., Harrison F. L., Wong K. M., Heft. R. E., Charnell Robert L., Lehmann Edward J., Mallon Lawrence G., Hatfield Cecile, Adams Gerald H., Johanning James, Talvitie Antti, Noll Kenneth E., Miller Terry, Smiarowski Joseph F., Willis Cleve E., Foster John H., Schlesinger Benjamin, Daetz Douglas, Lear Donald U., Smith Mona F., Hundemann Audrey S., Crockett Pernell W., Werner Kirk G., Carroll Thomas E., Maase David L., Genco Joseph E., Ifeadi Christopher N., Lowman F. G., Christensen S. W., Van Winkle W., Mattice J. S., Harrison Elizabeth A., Barker James C., Chesness Jerry L., Smith Ralph E., Shaheeen Donald G., Raney R. Keith, Borton T., Wezernak C. T., Raney R. K., Sherwani Jabbor K., Moreau David H., Eisenberg Norman A., Lynch Cornelius J., Breeding Roger J., Johnson J. D., Foster K. E., Mouat D. A., Clark R., Hyden John William, Owen, Wilfred, Bayfield, Neil G., Barrow, Graham C., Stolz, Stephanie B., Wienckowski, Louis A., Brown, Betram S., Keyfitz, Nathan, Wilson, W. L., Newman, Peter W. G., Bammi, Deepak, Bammi, Dalip, Goddard, James E., Chisholm, Tony, Walsh, Cliff, Brennan, Geoffrey, Thompson, K. S., Richardson, R., Jensen, Clayton E., Brown, Dail W., Mirabito, John A., Cowing, Thomas G., Binghamton, Suny, Siehl, George H., Albrecht, O. W., Alexander, Ariel, Barde, Jean -Philippe, Darby, William P., McMichael, Francis Clay, Dunlap, Robert W., Muckleston, Keith W., Frankenhoff, Charles A., Giulini, Lorenzo T., Wyatt, T., Black, Peter E., Keating, William Thomas, Leonard, M. E., Fisher, E. L., Brunelle, M. F., Dickinson, J. E., Pethig, Rudiger, Clapham, Jr., W. B., Boserup, Ester, James, Jr., Franklin J., Parenteau, Patrick A., Catz, Robert S., Seneca, Joseph J., Davis, Robert K., Sievering, H., Sinopoli, J., Gamble, Hays B., Bevins, Malcolm I., Cole, Gerald L., Donald, Donn Derr, Tobey, M., Domokos, Mikklos, Weber, Jean, Duckstein, Lucien, Knudson, Douglas M., Barron, J. C., Dickinson, T. E., Schwartz, S. I., Hansen, D. E., Myrup, L. O., Rogers, D. L., Bodege, R., Braatz, U., Heger, H., McConnell, K. E., Duff, Virginia A., Adede, A. O., Zeckhauser, Richard, Kolbye, A. C., Schussel, George, Pisano, Mark A., Bartolotta, R. J., Budnitz, Robert J., Holdren, John P., Wills, Richard H., Sen, P. K., Ghoshal, S. N., Wonders, William C., Bartolotta, Robert J., Leich, Harold H., Gwvnne, P., Miller, S. S., Picardi, Anthony C., Seifer, William W., Bowbrick, P., Hunt, S. E., Keays, J. L., Fisher, Anthony C., Peterson, Frederick M., Cesario, F. J., Knetsch, J. L., Wood, C., Lee, N., Puechl, Karl H., Robert, J., Hansen, David E., Foin, T. C., Wolpert, Julian, Moskow, Michael H., Phillips, Joseph A., Hicks, Jesse L., Nobbs, Christopher L., Pearce, David W., Schoenbau, Thomas J., Rosenberg, Ronald H., Ravenholt, R. T., Kim, K. D., Groves, David L., McCart, Gerald D., Ewald, Jr., W. R., Dando, W. A., Gebelein, C. A., Martin, W. H., Mason, S., Ostrovskii, A. A., Currie, David P., Payne, P. R., Rosentraub, Mark S., Warren, Robert, Irland, Lloyd C., Booth, A., Kolb, Kenneth H., Caldwell, Lynton K., Johnson, W. H., Brewer, Max C., Bowden, Gerald, Haney, Paul D., Logue, D. E., Sweeney, R. J., Egbuniwe, Nnamdi, Heron, N., Franssen, H. T., Wranglen, G., Fairfax, Sally K., Pinhey, Thoma K., Paterson, Karen W., Sitterlev, John H., Connaughton, Charles A., De Viedman, M. G., Leon, F., Coronado, R., Myers, John G., Nakamura, Leonard I., Madrid, Norman R., Bar-Shalom, Y., Cohen, A. J., Seldman, Neil N., Hardy, Jr., William E., Grissom, Curtis L., Quarles, Jr., John R., Gee, Edwin A., Chaudhri, D. P., Infanger, Craig L., Bordeauz, Jr., A. Frank, Dougal, Merwin D., Ganotis, C. G., Hopper, R. E., Boyd, J., Woodard, Kim, Haedrich, R. L., Thompson, R. G., Lievano, R. J., Stoneburner, D. L., Smock, L. A., Eichhorn, H. C., Montalvo, J. G., Lee, C. G., von Jeszensky, T., Dunn, I. J., Wilson, M. J., Swindle, Jr., D. W., Runove, T. G., Pearson, T. H., Rosenberg, R., Sharp, Jr., John M., Greist, David A., Kinard, J. T., Tisdale, J., Alexander, E., Stone, Ralph, Willis, Robert, Anderson, Donald R., Dracup, John A., Rogers, C. J., Hunter, John M., Cassola, Fabio, Lovari, Sandro, Tew, R. W., Egdorf, S. S., Deacon, J. E., Sly, George R., Brandvold, D. K., Popp, C. J., Brierley, J. A., Zeidler, Ryszard B., Gonzalez, R. H., Lapage, S. P., Cornish, Edward S., Ryerson, Foresman, D. K., Walejko, R. N., Paulson, W. H., Pendleton, J. W., Fowler, Bruce A., Minckler, Leon S., Wallis, I. G., Nebel, C., Gottschling, R. D., Unangst, P. C., O'Neill, H. J., Zintel, G. V., Reid, F., Ricci, L. J., Odum, Eugene P., Johnson, J. H., Sturino, E. E., Bourne, S., Richerson, Jim V., Cameron, E. Alan, Brown, Elizabeth A., Stopford, W., Goldwater, L. J., Gray, John, Jorgensen, S. E., Santhirasegaram, K., Chapman, J. D., Skelton, Thomas E., Stahl, D., Herzog, Jr., Henry W., Matsunaka, S., Kuwatsuka, S., Tatsukawa, R., Wakimoto, T., Moyle, Peter B., Kornilov, B. A., Timoshkina, V. A., Johnstone, Peter A., McMinn, James W., Hewlett, John D., Cunha, T. J., Cameron, Guy N., Blais, J. R., Macgregor, Alan, Martin, G. D., Mulholland, R. J., Thornton, K. W., Spano, L. A., Medeiros, J., Ostarhild, H., Minnick, D. R., Hayden, Bruce P., Dolan, Robert, Rendel, J., Lee, J. A., Leistra, M., Frye, R. D., Ramse, David, Safferman, R. S., Morris, Mary -Ellen, Lisella, Frank S., Johnson, Wilma, Lewis, Claudia, Kutt, E. C., Martin, D. F., Prakash, A., Kunkle, S. H., Mrak, E. M., Bruce, R. R., Harper, L. A., Leonard, R. A., Snyder, W. M., Thomas, A. W., Eckholm, Erik P., Snelling, John C., Veblen, Thomas T., Buckhouse, J. C., Gifford, G. F., Fosberg, F. R., Naveh, Z., Kelcey, J. G., Scanlon, John W., Lijinsky, W., Elias, Thomas S., Philip, M. S., Kverno, Nelson B., Mitchell, G. Clay, Gysin, H., Morita, M., Mimura, S., Ohi, G., Yagyu, H., Nishizawa, T., Worcester, B. K., Brun, L. J., Doering, E. J., Hiatt, V., Huff, J. E., Pfeffer, J. T., Liebman, J. C., Ray, William, Ramamurthy, V. C., Black, A. H., Coty, A., Kassler, H., Dixon, R. L., Trout, Thomas J., Smith, James L., McWhorter, David B., Rowe, M. C., Quinlan, A. V., Paynter, H. M., Born, D., Roth, D., Wall, G., Schindler, D. W., Frost, P. G. H., Siegfried, W. R., Cooper, J., MacDonald, S., Mason, C. F., Bar, F., Moore, G., Coldrick, John, Selman, P. H., Dempster, J. P., King, M. L., Lakhani, K. H., Evans, G. Clifford, Coote, D. R., Haith, D. A., Zwerman, P. J., Herricks, Edwin E., Shanholtz, Vernon O., Smith, V. K., Johnson, D. Gale, Mitsch, W. J., Fried, Maurice, Tanji, Kenneth K., Van De Pol, Ronald M., Dawson, Allan, Smith, Malcolm, McLaren, Neil, Cooley, James L., Moran, J. W., Witter, L. D., Tomlinson, E. J., Cheremisinoff, Paul N., Holcomb, William F., Hall, J. M., Kerut, E. G., Irico, J., Bower, L. C., Duggan, J. B., Cleasby, J. L., Klein, David H., Andren, Anders W., Bolton, Newell E., Joshi, Ramesh C., Duncan, Donald M., McMaster, Howard M., Russell, George A., Hochstein, Anatoly B., Elgohary, F. A., Brooks, D. J., Brainard, F. S., Ott, W. R., Thorn, G. C., Panicker, N. N., Middleton, A. C., Lawrence, A. W., Hannigan, John T., Post, R. F., Hall, D. G., White, K. E., Shaw, E. M., Sidwick, J. M., Preston, J. R., Nichol, Janet E., Maxwell, Bruce, Watson, M. B., Kammer, W. A., Langley, N. P., Selzer, L. A., Beck, R. L., Munn, Harold C., Peirano, Lawrence E., Cooper, Charles F., Kruger, Paul, Zebroski, E., Levenson, M., Mason, B. J., Rehberger, Glenn W., Field, A. A., Jones, John F., Penner, S. S., Black, Francis M., High, Larry E., Sigsby, John E., Janssens, M., Darns, R., Giebel, J., Dilaj, Michael, Lenard, John F., Beran, D. W., Linden, H. R., Bodle, W. W., Lee, B. S., Vyas, K. C., Golueke, Clarence G., McCurdy, P. H., Hines, W. G., Rickert, D. A., McKenzie, S. W., Bennett, J. P., Goldstein, Elliot, Ragaini, Richard C., Pearl, Richard Howard, Turner, Norma, Miller, Terry L., Noll, Kenneth E., Etzel, James E., Bell, John M., Lindermann, Eckhart G., Lancelot, Charles J., Lane, Dennis D., Stukel, James J., Lee, G. F., Morse, Frederick H., Simmons, Melvin K., Alpert, S. B., Lundberg, R. M., Schmidt, Richard A., Hill, George R., Anspaugh, Lynn R., Harem, F. E., Bielman, K. O., Worth, J. E., Kuester, J. L., Lutes, L., Henten, M. Patricia, Tazieff, Haroun, Patrick, P. K., Baker, Ralph N., Kalhammer, Fritz R., Schneider, Thomas R., Landwehr, J. Maciunas, Deininger, R. A., Rattien, Stephen, Eaton, David, Dezeeuw, R. E., Haney, E. B., Wong, R. B., De Planque Burke, Gail, Siegrist, Robert, Witt, Michael, Boyle, William C., Rickert, David A., Hines, Walter G., McKenzie, Stuart W., Brutsaert, W., Gross, G. W., McGehee, R. M., Hyzer, William G., Mohr, Adolph W., Wildman, S. V., Goldsmith, T. J., Sargent, Frederick O., Brande, Justin H., Work, Jr., Edgar A., Gilmer, David S., Hord, B. Michael, Brooner, William, Baraby, Frank, Snodgrass, W. J., O'Melia, C. R., Rollier, M. A., Kunz, R. G., Giannelli, J. F., Stensel, H. D., Moyer, W. W., Osman, F. P., Campbell, W. J., Wilson, E. M., Freeman, H. M., Hogan, B. J., Dick, R. I., Tangborn, Wendell V., Rasmussen, Lowell A., Ruff, James F., Skinner, Morris M., Winkley, Brian R., Simons, Daryl B., Dorratcague, Dennis E., Lanterman, B. A., Staudenmire, J. H., Fritz, Norman L., Williams, Richard D., Wood, Richard, Huillet, F. D., Muzyka, Ann, Fantasia, John F., Goodman, Joseph M., Anderl, Bernhard, Attmanspacher, Walter, Singh, Vijay P., Peleg, H., Scavia, D., Park, R. A., Niemann, Jr., Bernard J., Bonilla, Xavier A., Bruno, S. Richards, Rose, Richard A., Meyer, Charles F., Tempo, G E, Klumb, D., Maddock, Jr., Thomas, Chermisinoff, Paul N., Bethea, Robert M., Hellman, Thomas M., Laren, Oscar Bud, Leenheer, J. A., Malcolm, R. L., White, W. R., McNamara, John R., Windheim, L. S., Wodder, R. R., Smith, D. D., Mallan, G. M., Titlow, E. I., Peleg, M., Greco, I. R., Gregory, D. P., Pangborn, J. B., Somers, Edward V., Berg, Daniel, Fickett, Arnold P., Larsen, R. I., Heck, W. W., Cochran, Neal P., Ulaby, Fawwaz T., Bush, Thomas F., Cunningham, Ernest R., Nakada, M., Wyndham, H. B., Schulte, Harry F., Serpa, Douglas P., Young, R. L., Spell, J. E., Slu, H. M., Philip, R. H., Jones, E. R., Sprowl, James A., Kohout, Ladislav J., Gaines, Brian R., McCoy, K., Mejer, H., Reutlinger, Shlomo, Lieberman, M. A., LaNier, R., Crampton, C. B., Sabadell, J. Eleonora, Axtmann, Robert C., Josephson, J., Gutierrez, A. P., Regev, U., Summers, C. G., Daniels, A., Bach, W., Mairs, John W., Bengtsson, L., Oleckno, William A., Wildman, W. E., Neja, R. A., Clark, J. K., Larson, Don, Wagner, Frederick W., Durabb, Edwin J., Barnes, H. M., Homolya, J. B., Jacoby, Neil H., Kispert, R. G., Sadek, S. E., Wise, D. L., Nihoul, J. C. J., Foyster, A. M., Gessaman, Paul H., Sisler, Daniel G., Pinkham, C. F. A., Pearson, J. G., MacAdam, W. K., Gribbin, John, Schwartz, Seymour I., Green, F. H. W., Viscomi, B. V., Gray, S. L., McKean, J. R., Usher, M. B., Svestka, Milan, Eckholm, E. P., Johnston, H., Mausel, Paul W., Leivo, Carl Eric, Lewellen, Michael T., Nilles, Jack M., Gray, Paul, Campbell, Thomas C., Wogman, N. A., Bockris, John M., Jenne, E. A., Avotins, Peter, Nelson, D. W., Sommers, L. E., Scott, Frank M., Benz, L. C., Sandoval, F. M., Willis, W. O., Chapman, Peter F., MacDougall, E. B., Peakall, David B., Office of Technology Assessment, and Office of Science and Technology

Published
1977
Full Text
View/download PDF

9. Quote Vendors: A Ruffled Peace

Author

Bartolotta, R.

Subjects
Vendors, MS-DOS, UNIX, Stock Quotation Services, Competition, Networks, Workstations, Marketing Strategy, Demand, Market, History of Computing, Quotron Systems Inc. -- Statistics, Monchik-Weber Corp. -- Statistics
Published
1985

10. Design, synthesis, and biological evaluation of a new class of benzo[b]furan derivatives as antiproliferative agents, with in silico predicted antitubulin activity

Author

Antonio Palumbo Piccionello, Silvestre Buscemi, Francesco Mingoia, Roberta Bartolotta, Carla Gentile, Riccardo Delisi, Antonino Lauria, Annamaria Martorana, Lauria, A., Gentile, C., Mingoia, F., Palumbo Piccionello, A., Bartolotta, R., Delisi, R., Buscemi, S., and Martorana, A.

Subjects
0301 basic medicine, Cell cycle checkpoint, induced fit docking studie, antitubulin agents, 01 natural sciences, Biochemistry, HeLa and MCF-7 cell lines, HeLa, chemistry.chemical_compound, Tubulin, Furan, Drug Discovery, Imidazole, Moiety, biology, HeLa and MCF-7 cell line, G2/M phase, Tubulin Modulators, Molecular Docking Simulation, Antiproliferative Agents, MCF-7 Cells, Molecular Medicine, VLAK protocol, antitubulin agent, Stereochemistry, In silico, Substituent, 3-benzoylamino-5-(1H-imidazol-4-yl)methylaminobenzo[b]furans, Antineoplastic Agents, induced fit docking studies, antitumor agents, 03 medical and health sciences, Humans, colchicine binding site, Benzofurans, Cell Proliferation, Pharmacology, Binding Sites, 010405 organic chemistry, Organic Chemistry, Cell Cycle Checkpoints, 3-benzoylamino-5-(1H-imidazol-4-yl)methylaminobenzo[b]furan, biology.organism_classification, 0104 chemical sciences, Protein Structure, Tertiary, 030104 developmental biology, chemistry, antitumor agent, Drug Design, Colchicine, HeLa Cells
Abstract

A new series of 3-benzoylamino-5-(1H-imidazol-4-yl)methylaminobenzo[b]furans were synthesized and screened as antitumor agents. As a general trend, tested compounds showed concentration-dependent antiproliferative activity against HeLa and MCF-7 cancer cell lines, exhibiting GI50 values in the low micromolar range. In most cases, insertion of a methyl substituent on the imidazole moiety improved the antiproliferative activity. Therefore, methyl-imidazolyl-benzo[b]furans compounds were tested in cell cycle perturbation experiments, producing cell cycle arrest with proapoptotic effects. Their core similarity to known colchicine binding site binders led us to further study the structure features as antitubulin agents by in silico protocols. This article is protected by copyright. All rights reserved.

Published
2018
Full Text
View/download PDF

11. Does Ligand Symmetry Play a Role in the Stabilization of DNA G-Quadruplex Host-Guest Complexes?

Author

Antonino Lauria, Roberta Bartolotta, Ugo Perricone, Annamaria Martorana, Riccardo Bonsignore, Alessio Terenzi, Marco Tutone, Anna Maria Almerico, Giampaolo Barone, Lauria, A, Terenzi, A, Bartolotta, R, Bonsignore, R, Perricone, U, Tutone, M, Martorana, A, Barone, G, and Almerico, AM

Subjects
Pharmacology, Gene isoform, Ligand, Stereochemistry, Organic Chemistry, Antineoplastic Agents, DNA, Telomere, Ligands, G-quadruplex, Settore CHIM/08 - Chimica Farmaceutica, Biochemistry, Small molecule, G-Quadruplexes, chemistry.chemical_compound, Order (biology), chemistry, Settore CHIM/03 - Chimica Generale E Inorganica, Anticancer drugs, DNA G-quadruplex, host-guest complexes, ligand symmetry, point group symmetry, Drug Discovery, Molecular symmetry, Humans, Molecular Medicine, Stabilizer (chemistry)
Abstract

In efforts to find agents with improved biological activity against cancer cells, recent years have seen an increased interest in the study of small molecules able to bind the deoxyribonucleic acid (DNA) when it assumes secondary structures known as G-quadruplexes (G4s) preferring them over the B form. Currently, several compounds reported in literature have already shown to be good candidates as G4s DNA stabilizers. Even though some specific features for the G4s affinity are known, such as a π-delocalized system able to stack at the top/end of a G-tetrad and positively charged substituents able to interact with the grooves, it is not clear yet what kind of structural features affect more the G4 arrangement. This is mainly due to the structure heterogeneity of both the G4 stabilizer compounds and the DNA G4s isoforms. In this review, we aim to classify some known G4 binders by analyzing them from a new perspective surprisingly never approached up to date: the symmetry features. Molecular symmetry could be responsible for the specific binding mode to the G4-DNA but could also be crucial in determining different isoform affinity. We propose to classify the G4s stabilizers in five main point group symmetry classes. This classification could be useful to design new ligands able to stabilize a specific G-quadruplex isoform, in order to increase the selectivity of new potential anticancer G-quadruplex targeting drugs, a goal yet highly sought by researchers.

Published
2014

12. Double chained naphthalenes as G4 binders

Author

TERENZI, Alessio, BARTOLOTTA, Roberta, GENTILE, Carla, MARTORANA, Annamaria, BARONE, Giampaolo, ALMERICO, Anna Maria, LAURIA, Antonino, Terenzi, A, Bartolotta, R, Gentile, C, Martorana, A, Barone, G, Almerico, AM, and Lauria, A

Subjects
G-quadruplex, Settore CHIM/03 - Chimica Generale E Inorganica, Settore BIO/10 - Biochimica, anticancer drug, molecular modeling, biological activity, Settore CHIM/08 - Chimica Farmaceutica
Published
2014

13. Drugs Polypharmacology by in Silico Methods: New Opportunities in Drug Discovery

Author

Carla Gentile, Ugo Perricone, Antonino Lauria, Annamaria Martorana, Riccardo Bonsignore, Roberta Bartolotta, Lauria, A, Bonsignore, R, Bartolotta, R, Perricone, U, Martorana, A, and Gentile, C

Subjects
0301 basic medicine, Drug, Polypharmacology, media_common.quotation_subject, In silico, Nanotechnology, 03 medical and health sciences, Biological and chemical databases, computational methods, Drugs, multitarget activity, polypharmacology, repurposing, Drug Discovery, Medicine, Humans, Computer Simulation, Repurposing, media_common, Pharmacology, Molecular Structure, business.industry, Drug discovery, Drug repositioning, Identification (information), 030104 developmental biology, Risk analysis (engineering), business, Chemical database, Software
Abstract

Background Polypharmacology, defined as the modulation of multiple proteins rather than a single target to achieve a desired therapeutic effect, has been gaining increasing attention since 1990s, when industries had to withdraw several drugs due to their adverse effects, leading to permanent injuries or death, with multi-billiondollar legal damages. Therefore, if up to then the "one drug one target" paradigm had seen many researchers interest focused on the identification of selective drugs, with the strong expectation to avoid adverse drug reactions (ADRs), very recently new research strategies resulted more appealing even as attempts to overcome the decline in productivity of the drug discovery industry. Methods Polypharmacology consists of two different approaches: the former, concerning a single drug interacting with multiple targets related to only one disease pathway; the latter, foresees a single drug's action on multiple targets involved in multiple disease pathways. Both new approaches are strictly connected to the discovery of new feasible off targets for approved drugs. Results In this review, we describe how the in silico facilities can be a crucial support in the design of polypharmacological drug. The traditional computational protocols (ligand based and structure based) can be used in the search and optimization of drugs, by using specific filters to address them against the polypharmacology (fingerprints, similarity, etc.). Moreover, we dedicated a paragraph to biological and chemical databases, due to their crucial role in polypharmacology. Conclusion Multitarget activities provide the basis for drug repurposing, a slightly different issue of high interest as well, which is mostly applied on a single target involved in more than one diseases. In this contest, computational methods have raised high interest due to the reached power of hardware and software in the manipulation of data.

14. Cyclopentyl Methyl Ether: An Elective Ecofriendly Ethereal Solvent in Classical and Modern Organic Chemistry.

Author

Azzena U, Carraro M, Pisano L, Monticelli S, Bartolotta R, and Pace V

Abstract

Solvents represent one of the major contributions to the environmental impact of fine-chemical synthesis. As a result, the use of environmentally friendly solvents in widely employed reactions is a challenge of vast real interest in contemporary organic chemistry. Within this Review, a great variety of examples showing how cyclopentyl methyl ether has been established as particularly useful for this purpose are reported. Indeed, its low toxicity, high boiling point, low melting point, hydrophobicity, chemical stability towards a wide range of conditions, exceptional stability towards the abstraction of hydrogen atoms, relatively low latent heat of vaporization, and the ease with which it can be recovered and recycled enable its successful employment as a solvent in a wide range of synthetic applications, including organometallic chemistry, catalysis, biphasic reactions, oxidations, and radical reactions., (© 2018 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA.)

Published
2019
Full Text
View/download PDF

15. Design, synthesis, and biological evaluation of a new class of benzo[b]furan derivatives as antiproliferative agents, with in silico predicted antitubulin activity.

Author

Lauria A, Gentile C, Mingoia F, Palumbo Piccionello A, Bartolotta R, Delisi R, Buscemi S, and Martorana A

Subjects
Antineoplastic Agents pharmacology, Benzofurans metabolism, Benzofurans pharmacology, Binding Sites, Cell Cycle Checkpoints drug effects, Cell Proliferation drug effects, Colchicine chemistry, Colchicine metabolism, HeLa Cells, Humans, MCF-7 Cells, Molecular Docking Simulation, Protein Structure, Tertiary, Tubulin chemistry, Tubulin Modulators pharmacology, Antineoplastic Agents chemical synthesis, Benzofurans chemistry, Drug Design, Tubulin metabolism, Tubulin Modulators chemical synthesis
Abstract

A new series of 3-benzoylamino-5-(1H-imidazol-4-yl)methylaminobenzo[b]furans were synthesized and screened as antitumor agents. As a general trend, tested compounds showed concentration-dependent antiproliferative activity against HeLa and MCF-7 cancer cell lines, exhibiting GI 50 values in the low micromolar range. In most cases, insertion of a methyl substituent on the imidazole moiety improved the antiproliferative activity. Therefore, methyl-imidazolyl-benzo[b]furans compounds were tested in cell cycle perturbation experiments, producing cell cycle arrest with proapoptotic effects. Their core similarity to known colchicine binding site binders led us to further study the structure features as antitubulin agents by in silico protocols., (© 2017 John Wiley & Sons A/S.)

Published
2018
Full Text
View/download PDF

16. Drugs Polypharmacology by In Silico Methods: New Opportunities in Drug Discovery.

Author

Lauria A, Bonsignore R, Bartolotta R, Perricone U, Martorana A, and Gentile C

Subjects
Humans, Molecular Structure, Software, Computer Simulation, Drug Discovery, Polypharmacology
Abstract

Background: Polypharmacology, defined as the modulation of multiple proteins rather than a single target to achieve a desired therapeutic effect, has been gaining increasing attention since 1990s, when industries had to withdraw several drugs due to their adverse effects, leading to permanent injuries or death, with multi-billiondollar legal damages. Therefore, if up to then the "one drug one target" paradigm had seen many researchers interest focused on the identification of selective drugs, with the strong expectation to avoid adverse drug reactions (ADRs), very recently new research strategies resulted more appealing even as attempts to overcome the decline in productivity of the drug discovery industry., Methods: Polypharmacology consists of two different approaches: the former, concerning a single drug interacting with multiple targets related to only one disease pathway; the latter, foresees a single drug's action on multiple targets involved in multiple disease pathways. Both new approaches are strictly connected to the discovery of new feasible off targets for approved drugs., Results: In this review, we describe how the in silico facilities can be a crucial support in the design of polypharmacological drug. The traditional computational protocols (ligand based and structure based) can be used in the search and optimization of drugs, by using specific filters to address them against the polypharmacology (fingerprints, similarity, etc.). Moreover, we dedicated a paragraph to biological and chemical databases, due to their crucial role in polypharmacology., Conclusion: Multitarget activities provide the basis for drug repurposing, a slightly different issue of high interest as well, which is mostly applied on a single target involved in more than one diseases. In this contest, computational methods have raised high interest due to the reached power of hardware and software in the manipulation of data.

Published
2016
Full Text
View/download PDF

17. Primary skeletal leiomyosarcoma.

Author

Ngo AV, Bartolotta R, Chew F, and Linnau K

Abstract

Leiomyosarcoma typically occurs within the uterus, gastrointestinal tract, and mesentery. Primary skeletal leiomyosarcoma is exceedingly rare. The radiographic appearance is similar to that of other aggressive sarcomas of the bone. Definitive diagnosis is achieved through biopsy or excision and pathologic review.

Published
2015
Full Text
View/download PDF

18. Avulsion fractures in the foot: telltale radiographic signs to avoid mismanagement.

Author

Rotman J, Loftus M, and Bartolotta R

Subjects
Foot diagnostic imaging, Humans, Radiography, Foot Injuries diagnostic imaging, Fractures, Bone diagnostic imaging
Abstract

Due to similar clinical presentations, avulsion fractures are frequently missed on initial exam and categorically treated as "sprain" not otherwise specified. However, delays in appropriate diagnosis and treatment can result in further injury and long-term disability. This article will review multiple foot avulsion fractures, their respective mechanisms of injury, the clinical and radiographic presentations, and the most appropriate courses of treatment., (Published by Elsevier Inc.)

Published
2015
Full Text
View/download PDF

19. Synthesis, antiproliferative activity, and in silico insights of new 3-benzoylamino-benzo[b]thiophene derivatives.

Author

Martorana A, Gentile C, Perricone U, Piccionello AP, Bartolotta R, Terenzi A, Pace A, Mingoia F, Almerico AM, and Lauria A

Subjects
Antineoplastic Agents chemical synthesis, Antineoplastic Agents chemistry, Cell Cycle drug effects, Cell Proliferation drug effects, Computer Simulation, Dose-Response Relationship, Drug, Drug Screening Assays, Antitumor, HeLa Cells, Humans, Molecular Structure, Structure-Activity Relationship, Thiophenes chemistry, Antineoplastic Agents pharmacology, Thiophenes chemical synthesis, Thiophenes pharmacology
Abstract

A new series of 3-benzoylamino-5-imidazol-5-yl-benzo[b]thiophenes and the parent amino derivatives were synthesized and screened as antitumor agents. All tested compounds showed concentration-dependent antiproliferative activity profile against HeLa cell line, exhibiting GI50 values in the low micromolar range. The most active compounds were tested in cell cycle perturbation experiments. A rapid accumulation of cells in the G2/M phase, with a concomitant reduction of cells in both the S and G0/G1 phases, was observed, suggesting that cell exposure to selected derivatives produces mitotic failure. To rationalize the biological results, the 3-benzoylamino-benzo[b]thiophenes were analyzed through the in silico VLAK protocol. Compounds presenting the 3,4,5-trimethoxy-benzoyl moiety were in silico classified as potential antimitotic agents or topoisomerase II inhibitors, in good agreement with the biological studies., (Copyright © 2014 Elsevier Masson SAS. All rights reserved.)

Published
2015
Full Text
View/download PDF

20. Does ligand symmetry play a role in the stabilization of DNA G-quadruplex host-guest complexes?

Author

Lauria A, Terenzi A, Bartolotta R, Bonsignore R, Perricone U, Tutone M, Martorana A, Barone G, and Almerico AM

Subjects
Antineoplastic Agents chemistry, DNA metabolism, Humans, Ligands, Telomere chemistry, Telomere metabolism, DNA chemistry, G-Quadruplexes
Abstract

In efforts to find agents with improved biological activity against cancer cells, recent years have seen an increased interest in the study of small molecules able to bind the deoxyribonucleic acid (DNA) when it assumes secondary structures known as G-quadruplexes (G4s) preferring them over the B form. Currently, several compounds reported in literature have already shown to be good candidates as G4s DNA stabilizers. Even though some specific features for the G4s affinity are known, such as a π-delocalized system able to stack at the top/end of a G-tetrad and positively charged substituents able to interact with the grooves, it is not clear yet what kind of structural features affect more the G4 arrangement. This is mainly due to the structure heterogeneity of both the G4 stabilizer compounds and the DNA G4s isoforms. In this review, we aim to classify some known G4 binders by analyzing them from a new perspective surprisingly never approached up to date: the symmetry features. Molecular symmetry could be responsible for the specific binding mode to the G4-DNA but could also be crucial in determining different isoform affinity. We propose to classify the G4s stabilizers in five main point group symmetry classes. This classification could be useful to design new ligands able to stabilize a specific G-quadruplex isoform, in order to increase the selectivity of new potential anticancer G-quadruplex targeting drugs, a goal yet highly sought by researchers.

Published
2014
Full Text
View/download PDF

21. Skeletal imaging effects of pamidronate therapy in osteosarcoma patients.

Author

Price AP, Abramson SJ, Hwang S, Chou A, Bartolotta R, Meyers P, and Katz DS

Subjects
Adolescent, Adult, Bone Neoplasms pathology, Child, Cisplatin therapeutic use, Doxorubicin therapeutic use, Female, Humans, Magnetic Resonance Imaging, Male, Methotrexate therapeutic use, Osteosarcoma pathology, Pamidronate, Positron-Emission Tomography, Retrospective Studies, Tomography, X-Ray Computed, Treatment Outcome, Antineoplastic Agents therapeutic use, Bone Neoplasms drug therapy, Diphosphonates therapeutic use, Osteosarcoma drug therapy
Abstract

Background: After observing metaphyseal changes in pediatric and young adult patients with osteosarcoma who were treated with pamidronate, we initiated a retrospective study to identify bone findings on computed radiography of the chest and extremities, chest CT, extremity MRI, and radionuclide bone scans in this population., Objective: To review the generalized skeletal imaging findings on computed radiography, CT, and MR examinations in patients with osteosarcoma (OS) receiving pamidronate., Materials and Methods: A retrospective review of 40 patients with newly diagnosed OS (mean age, 16.5 years) receiving pamidronate with chemotherapy were identified at one institution. Computed radiography, CT, MR, and bone scans on 36 patients were reviewed for osseous changes., Results: Dense metaphyseal bands at the growth plates in long bones, epiphyseal ossification centers, anterior rib ends, sternum and spine were observed. Osseous changes occurred on CT in 69% of patients, and on computed chest radiography in 53%. Bone-within-bone appearance in the spine and ossification centers was identified on computed radiography in 36%., Conclusion: OS patients treated with pamidronate can develop metaphyseal sclerotic bands as well as epiphyseal and vertebral endplate sclerosis progressing to a bone-within-bone appearance. Findings occur more frequently in younger patients with open epiphyses.

Published
2011
Full Text
View/download PDF

22. Pelvic cake kidney with a solitary ureter and bilateral congenital absence of the vas deferens.

Author

Schwartz MJ, Bartolotta R, Brill PW, Kovanlikaya A, and Hanna M

Subjects
Child, Preschool, Humans, Male, Abnormalities, Multiple diagnosis, Abnormalities, Multiple surgery, Kidney abnormalities, Ureter abnormalities, Vas Deferens abnormalities
Abstract

Cross-fused renal ectopia is an uncommon anomaly, typically drained by 2 ureters. We present a rare case of a patient with bilateral absence of the vas deferens found to have a "cake" or "lump" kidney with fused collecting systems drained by a single ureter., (2010 Elsevier Inc. All rights reserved.)

Published
2010
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results